FORTRESS BIOTECH INC's ticker is FBIO and the CUSIP is 34960Q109. A total of 67 filers reported holding FORTRESS BIOTECH INC in Q2 2022. The put-call ratio across all filers is 0.18 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $12,889 | -76.4% | 44,400 | -55.4% | 0.00% | -100.0% |
| Q2 2023 | $54,698 | -39.9% | 99,450 | -10.4% | 0.00% | 0.0% |
| Q1 2023 | $90,979 | -10.8% | 110,950 | -28.7% | 0.00% | 0.0% |
| Q4 2022 | $101,951 | -99.9% | 155,650 | -50.6% | 0.00% | 0.0% |
| Q3 2022 | $135,135,000 | +103056.5% | 315,100 | +101.9% | 0.00% | 0.0% |
| Q2 2022 | $131,000 | -39.9% | 156,100 | -2.8% | 0.00% | -50.0% |
| Q1 2022 | $218,000 | -48.9% | 160,550 | -6.0% | 0.00% | -50.0% |
| Q4 2021 | $427,000 | -22.4% | 170,813 | +0.0% | 0.00% | -20.0% |
| Q3 2021 | $550,000 | -7.1% | 170,763 | +3.0% | 0.01% | -28.6% |
| Q2 2021 | $592,000 | -0.7% | 165,763 | -1.8% | 0.01% | -12.5% |
| Q1 2021 | $596,000 | -3.6% | 168,763 | -7.1% | 0.01% | +14.3% |
| Q4 2020 | $618,000 | -99.9% | 181,713 | +4.4% | 0.01% | -46.2% |
| Q3 2020 | $703,000,000 | – | 174,013 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opaleye Management Inc. | 3,830,000 | $10,264,000 | 2.07% |
| SHIKIAR ASSET MANAGEMENT INC | 345,500 | $926,000 | 0.42% |
| Nantahala Capital Management | 4,424,938 | $11,859,000 | 0.36% |
| FNY Investment Advisers, LLC | 175,000 | $469,000 | 0.27% |
| Telemetry Investments, L.L.C. | 20,376 | $55,000 | 0.15% |
| CPWM, LLC | 406,267 | $1,089,000 | 0.12% |
| 683 Capital Management, LLC | 200,000 | $536,000 | 0.04% |
| B. Riley Wealth Advisors, Inc. | 57,491 | $154,000 | 0.01% |
| Walleye Capital LLC | 15,000 | $40,000 | 0.01% |
| ACADIAN ASSET MANAGEMENT LLC | 720,803 | $1,932,000 | 0.01% |